AI MARKET SCANNING

Ardelyx, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +3.23%
MAX GAP RECORD +28.34%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ARDX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
-16.84%
Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE)
-5.21%
Feb 19, 2026 Earnings Release 2026-02-19 (AFTER CLOSE)
-3.71%
Oct 30, 2025 Earnings Release 2025-10-30 (AFTER CLOSE)
+28.34%
Aug 04, 2025 Earnings Release 2025-08-04 (AFTER CLOSE)
+15.60%
Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE)
+0.09%
Feb 20, 2025 Earnings Release 2025-02-20 (BEFORE OPEN)
-10.38%
Oct 31, 2024 Earnings Release 2024-10-31 (AFTER CLOSE)
+2.04%

VOLATILITY & GAP BIAS

AVG GAP MOVE 9.8%
Bullish Gaps (8)
Bearish Gaps (6)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ARDX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗